DEF 14A

Company

Lexaria Bioscience Corp.

Filed

May 26, 2020

Period of Report

May 13, 2020

Accession Number

0001640334-20-001310

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →